4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000950170-24-009094
Options or other derivatives
- Chief Financial Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Musso Alan A Chief Financial Officer | 2024-01-26 | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | D | ||
Loading xslF345X05/ownership.xml…